miR-20a and miR-290, multi-faceted players with a role in tumourigenesis and senescence

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 11, 2010, Pages 2633-2640

  Rizzo, Milena ^a   Mariani, Laura ^a   Pitto, Letizia ^a   Rainaldi, Giuseppe ^a,b   Simili, Marcella ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b ISTITUTO TOSCANO TUMORI   (Italy)

Author keywords

Leukaemia lymphoma related factor; MiR 20a and miR 290; Mouse embryo fibroblasts; Senescence; Tumour suppressors

Indexed keywords

MICRORNA; MIRN20 MICRORNA, HUMAN; MIRN290 MICRORNA, MOUSE;

ANIMAL; ARTICLE; CELL AGING; GENETICS; HUMAN; MOUSE; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELL AGING; HUMANS; MICE; MICRORNAS; NEOPLASMS;

EID: 78649697528     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01173.x     Document Type: Article

References (73)

1. Dimri GP, Lee X, Basile G, et al A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA. 1995; 92: 9363-7.
2. Suzuki T, Minagawa S, Michishita E, et al Induction of senescence-associated genes by 5-bromodeoxyuridine in HeLa cells. Exp Gerontol. 2001; 36: 465-74.
3. D'Adda di Fagagna F, Reaper PM, Clay-Farrace L, et al A DNA damage checkpoint response in telomere-initiated senescence. Nature. 2003; 426: 194-8.
4. Chen JH, Hales CN, Ozanne SE. DNA damage, cellular senescence and organismal ageing: causal or correlative Nucleic Acids Res. 2007; 35: 7417-28.
5. Parrinello S, Samper E, Krtolica A, et al Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol. 2003; 5: 741-7.
6. Di Micco R, Fumagalli M, Cicalese A, et al Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature. 2006; 444: 638-42.
7. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell. 2005; 120: 513-22.
8. Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell. 2007; 130: 223-33.
9. Bringold F, Serrano M. Tumor suppressors and oncogenes in cellular senescence. Exp Gerontol. 2000; 35: 317-29.
10. Lundberg AS, Hahn WC, Gupta P, et al Genes involved in senescence and immortalization. Curr Opin Cell Biol. 2000; 12: 705-9.
11. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 2001; 11: S27-31.
12. Sharpless NE. INK4a/ARF: a multifunctional tumor suppressor locus. Mutat Res. 2005; 576: 22-38.
13. Lowe SW, Sherr CJ. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev. 2003; 13: 77-83.
14. Helmrich A, Lee S, O'Brien P, et al Recurrent chromosomal aberrations in INK4a/ARF defective primary lymphomas predict drug responses in vivo. Oncogene. 2005; 24: 4174-82.
15. Grillari J, Grillari-Voglauer R. Novel modulators of senescence, aging, and longevity: small non-coding RNAs enter the stage. Exp Gerontol. 2010; 45: 302-11.
16. Zhang C. Novel functions for small RNA molecules. Curr Opin Mol Ther. 2009; 11: 641-51.
17. Davalos V, Esteller M. MicroRNAs and cancer epigenetics: a macrorevolution. Curr Opin Oncol. 2010; 22: 35-45.
18. Volinia S, Calin GA, Liu CG, et al A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 2006; 103: 2257-61.
19. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6: 259-69.
20. Kent OA, Mendell JT. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene. 2006; 25: 6188-96.
21. Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Annu Rev Med. 2009; 60: 167-79.
22. Shenouda SK, Alahari SK. MicroRNA function in cancer: oncogene or a tumor suppressor Cancer Metastasis Rev. 2009; 28: 369-78.
23. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight Nat Rev Genet. 2008; 9: 102-14.
24. Lu J, Getz G, Miska EA, et al MicroRNA expression profiles classify human cancers. Nature. 2005; 435: 834-8.
25. Johnson SM, Grosshans H, Shingara J, et al RAS is regulated by the let-7 microRNA family. Cell. 2005; 120: 635-47.
26. Nishino J, Kim I, Chada K, et al Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf Expression. Cell. 2008; 135: 227-39.
27. Tazawa H, Tsuchiya N, Izumiya M, et al Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA. 2007; 104: 15472-7.
28. Yamakuchi M, Lowenstein CJ. MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle. 2009; 8: 712-5.
29. Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ. 2010; 17: 193-9.
30. Chang TC, Yu D, Lee YS, et al Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet. 2008; 40: 43-50.
31. Kota J, Chivukula RR, O'Donnell KA, et al Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 2009; 137: 1005-17.
32. Sander S, Bullinger L, Klapproth K, et al MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood. 2008; 112: 4202-12.
33. Gil J, Peters G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol. 2006; 7: 667-77.
34. Sachdeva M, Zhu S, Wu F, et al p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA. 2009; 106: 3207-12.
35. Fabbri M, Garzon R, Cimmino A, et al MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA. 2007; 104: 15805-10.
36. Xiong Y, Fang JH, Yun JP, et al Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology. 2010; 51: 836-45.
37. Park SY, Lee JH, Ha M, et al miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol. 2009; 16: 23-9.
38. Hossain A, Kuo MT, Saunders GF. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol. 2006; 26: 8191-201.
39. Huang L, Luo J, Cai Q, et al MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Int J Cancer. 2010; doi:.
40. Park C, Lee I, Kang WK. E2F-1 is a critical modulator of cellular senescence in human cancer. Int J Mol Med. 2006; 17: 715-20.
41. Poliseno L, Pitto L, Simili M, et al The proto-oncogene LRF is under post-transcriptional control of MiR-20a: implications for senescence. PLoS One. 2008; 3: e2542.
42. Pitto L, Rizzo M, Simili M, et al miR-290 acts as a physiological effector of senescence in mouse embryo fibroblasts. Physiol Genomics. 2009; 39: 210-8.
43. Maeda T, Hobbs RM, Merghoub T, et al Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature. 2005; 433: 278-85.
44. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120: 15-20.
45. Hayashita Y, Osada H, Tatematsu Y, et al A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 2005; 65: 9628-32.
46. Venturini L, Battmer K, Castoldi M, et al Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood. 2007; 109: 4399-405.
47. He L, Thomson JM, Hemann MT, et al A microRNA polycistron as a potential human oncogene. Nature. 2005; 435: 828-33.
48. Eiriksdottir G, Johannesdottir G, Ingvarsson S, et al Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis. Eur J Cancer. 1998; 34: 2076-81.
49. Lin YW, Sheu JC, Liu LY, et al Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions. Eur J Cancer. 1999; 35: 1730-4.
50. Shao J, Li Y, Wu Q, et al High frequency loss of heterozygosity on the long arms of chromosomes 13 and 14 in nasopharyngeal carcinoma in Southern China. Chin Med J. 2002; 115: 571-5.
51. O'Donnell KA, Wentzel EA, Zeller KI, et al c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 2005; 435: 839-43.
52. Sylvestre Y, De Guire V, Querido E, et al An E2F/miR-20a autoregulatory feedback loop. J Biol Chem. 2007; 282: 2135-43.
53. Woods K, Thomson JM, Hammond SM. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem. 2007; 282: 2130-4.
54. Ghosh R, Nadiminty N, Fitzpatrick JE, et al Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity. J Biol Chem. 2005; 280: 5812-9.
55. Pitto L, Ripoli A, Cremisi F, et al microRNA(interference) networks are embedded in the gene regulatory networks. Cell Cycle. 2008; 7: 2458-61.
56. Le MT, Teh C, Shyh-Chang N, et al MicroRNA-125b is a novel negative regulator of p53. Genes Dev. 2009; 23: 862-76.
57. Serrano M, Lin AW, McCurrach ME, et al Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997; 88: 593-602.
58. Bracken AP, Kleine-Kohlbrecher D, Dietrich N, et al The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev. 2007; 21: 525-30.
59. Meloche S, Pouyssegur J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene. 2007; 26: 3227-39.
60. Marson A, Levine SS, Cole MF, et al Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell. 2008; 134: 521-33.
61. Wang Y, Baskerville S, Shenoy A, et al Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat Genet. 2008; 40: 1478-83.
62. Judson RL, Babiarz JE, Venere M, et al Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat Biotechnol. 2009; 27: 459-61.
63. Melton C, Judson RL, Blelloch R. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature. 2010; 463: 621-6.
64. Gu P, Reid JG, Gao X, et al Novel microRNA candidates and miRNA-mRNA pairs in embryonic stem (ES) cells. PLoS One. 2008; 3: e2548.
65. Gunaratne PH. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells Curr Stem Cell Res Ther. 2009; 4: 168-77.
66. Barh D, Malhotra R, Ravi B, et al Microrna let-7: an emerging next-generation cancer therapeutic. Curr Oncol. 2010; 17: 70-80.
67. Chen X, Guo X, Zhang H, et al Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene. 2009; 28: 1385-92.
68. Clape C, Fritz V, Henriquet C, et al miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. PLoS One. 2009; 4: e7542.
69. Strillacci A, Griffoni C, Sansone P, et al MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp Cell Res. 2009; 315: 1439-47.
70. Su H, Yang JR, Xu T, et al MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 2009; 69: 1135-42.
71. Friedman JM, Liang G, Liu CC, et al The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. Cancer Res. 2009; 69: 2623-9.
72. Gebeshuber CA, Zatloukal K, Martinez J. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep. 2009; 10: 400-5.
73. Scott GK, Goga A, Bhaumik D, et al Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem. 2007; 282: 1479-86.